Antimüllerian hormone levels and numbers and sizes of antral follicles in regularly menstruating women of reproductive age referenced to true ovulation.

Slides:



Advertisements
Similar presentations
Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States  David B. Seifer, M.D., Valerie.
Advertisements

Direct vitamin D3 actions on rhesus macaque follicles in three-dimensional culture: assessment of follicle survival, growth, steroid, and antimüllerian.
Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M
Variation in circulating antimüllerian hormone precursor during the periovulatory and acute postovulatory phases of the human ovarian cycle  Michael W.
Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation  W. Hamish B. Wallace, M.D., Thomas W. Kelsey, Ph.D.,
Longitudinal changes in maternal serum concentrations of antimüllerian hormone in individual women during conception cycles and early pregnancy  Kristina.
Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women  Ana Direito, M.D., Sébastien.
Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization.
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization  Antonio La Marca,
Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization–intracytoplasmic.
Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study 
Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc
Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M
Patient-tailored ovarian stimulation for in vitro fertilization
Antimüllerian hormone levels decrease in women using combined contraception independently of administration route  Sanna Kallio, M.D., Johanna Puurunen,
Rene Ecochard, M. D. , Ph. D. , Thomas Bouchard, M. D. , Rene Leiva, M
What is the optimal follicular size before triggering ovulation in intrauterine insemination cycles with clomiphene citrate or letrozole? An analysis.
Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles  Angela R. Baerwald, Ph.D.,
Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,
Role of ovarian reserve markers, antimüllerian hormone and antral follicle count, as aneuploidy markers in ongoing pregnancies and miscarriages  Maribel.
Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women  Ellen W. Freeman, Ph.D.,
Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth  Scott M. Nelson, M.R.C.O.G.,
Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained.
Antral follicle count as a predictor of ovarian responsiveness in women with endometriomas or with a history of surgery for endometriomas  Laura Benaglia,
The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.
Orhan Bukulmez, M. D. , Qin Li, M. S. , Bruce R. Carr, M. D
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count  Simone L. Broer, B.Sc., Ben Willem J.
Partnered sexual activity moderates menstrual cycle–related changes in inflammation markers in healthy women: an exploratory observational study  Tierney.
The impact of consumer affordability on access to assisted reproductive technologies and embryo transfer practices: an international analysis  Georgina.
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
A comparison of blood spot vs
Occurrence of postmenopausal-like acidic follicle-stimulating hormone (FSH) isoforms precedes the rise of FSH before menopause  Chris M.G. Thomas, Ph.D.,
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Does preoperative antimüllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis?  Emanuela Stochino-Loi,
Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.
Urinary cytokine and chemokine profiles across the menstrual cycle in healthy reproductive-aged women  Brian W. Whitcomb, Ph.D., Sunni L. Mumford, Ph.D.,
Angela R. Baerwald, Ph. D. , Olufemi A. Olatunbosun, M. D. , Roger A
Modification of the Beckman-Coulter second-generation enzyme-linked immunosorbent assay protocol improves the reliability of serum antimüllerian hormone.
Albert Hsu, M. D. , Margaret Arny, Ph. D. , Alexander B. Knee, M. S
Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding study  Donald Tredway, M.D., Ph.D.,
Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling.
Microdose flare protocol with interrupted follicle stimulating hormone and added androgen for poor responders—an observational pilot study  Frederic Mitri,
Links between age at menarche, antral follicle count, and body mass index in African American and European American women  Sonya M. Schuh, Ph.D., Julia.
René Ecochard, M. D. Ph. D. , Agnes Guillerm, M. D. , René Leiva, M. D
Benny Almog, M. D. , Fady Shehata, M. B. , B. Ch. , M. Sc
David E. Reichman, M.D., Dan Goldschlag, M.D., Zev Rosenwaks, M.D. 
Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation  Nam D. Tran, M.D., Ph.D., Lusine Aghajanova, M.D.,
Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis  Reshef Tal,
Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis.
Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: a.
Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction–intrauterine insemination to in vitro.
Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception  Lauren N.C. Johnson,
Sources of heterogeneities in estimating the prevalence of endometriosis in infertile and previously fertile women  Sun-Wei Guo, Ph.D., Yuedong Wang,
Prospective cohort study of three- versus two-dimensional ultrasound for prediction of oocyte maturity  Doron Shmorgun, M.D., Edward Hughes, M.D., Patrick.
Clinical uses of anti-Müllerian hormone assays: pitfalls and promises
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis.
Circulating microRNAs as potential biomarkers for endometriosis
Antral follicle counts are strongly associated with live-birth rates after assisted reproduction, with superior treatment outcome in women with polycystic.
A woman with premature ovarian failure induced by Tripterygium wilfordii Hook.f. gives birth to a healthy child  Xin Chen, M.D., M.Sc., Shi-ling Chen,
Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients  Scott M. Nelson, Ph.D., Martina C. Messow,
The play of chance Fertility and Sterility
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function  David H. Barad, M.D., M.S., Andrea Weghofer,
Anastrozole single-dose protocol in women with oligo- or anovulatory infertility: results of a randomized phase II dose–response study  Donald Tredway,
Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve  Norbert.
Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle- stimulating hormone (FSH) in normoandrogenic ovulatory women.
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three- dimensional ultrasound determinants of ovarian reserve in the prediction.
Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated.
Presentation transcript:

Antimüllerian hormone levels and numbers and sizes of antral follicles in regularly menstruating women of reproductive age referenced to true ovulation day  Christian Gnoth, M.D., Ph.D., Judith Roos, M.D., David Broomhead, Ph.D., Julia Schiffner, Dipl.-Stat., Erhard Godehardt, Ph.D., Günter Freundl, M.D., Ph.D., Sarah Johnson, Ph.D.  Fertility and Sterility  Volume 104, Issue 6, Pages 1535-1543.e4 (December 2015) DOI: 10.1016/j.fertnstert.2015.08.027 Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Figure 1 AMH fluctuations and AFCs by day to true ovulation. Median AMH level with 10th to 90th percentile range and 90th percentiles of the AFC in seven size classes by day relative to objective ovulation for all days with n > 2 samples. The number of circles represents the 90th percentile of the AFC, while their diameter indicates the size class (2–4, 5–7, 8–10, 11–13, 14–16, 17–19, ≥20 mm, represented by size of circle [from smallest to largest]). Fertility and Sterility 2015 104, 1535-1543.e4DOI: (10.1016/j.fertnstert.2015.08.027) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Fluctuations in the level of AMH by day to true ovulation. (A) Periovular decrease. AMH levels for 33 volunteers with basal AMH >1 ng/mL relative to day of ovulation. The regression line (representing average AMH levels over volunteers per day) shows a significant decrease of AMH around ovulation (−5 to +2 days), with a nadir on day +2 of −14.76%. (B) Luteal increase. AMH levels for 33 volunteers with basal AMH >1 ng/mL relative to day of ovulation. The regression line (illustrating average AMH levels over volunteers per day) shows a small, statistically not significant trend to higher mean levels of AMH toward the end of the luteal phase. Fertility and Sterility 2015 104, 1535-1543.e4DOI: (10.1016/j.fertnstert.2015.08.027) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Figure 3 AFCs per size class to AMH levels for cycle days 4–7 (approach 1). (A) AFCs (y-axis) for AMH levels (x-axis) measured on cycle days 4–7 per size class and in total. AMH levels were stratified to different size classes of antral follicles visible with high-resolution ultrasound. Ultrasound measurement of follicles less than 7 mm in diameter is not very precise, therefore, a summarizing class 2–7 mm is included. All antral follicles of all classes were measured on every visit. The regression lines correspond to the coefficients in Supplemental Table 2. The gray bands represent pointwise 95% prediction intervals, which cover the follicle count corresponding to the measured AMH level on cycle days 4–7 with a probability of 95%. (B) Regression lines and prediction intervals for three common coverage probabilities (80%, 90%, 95%). Fertility and Sterility 2015 104, 1535-1543.e4DOI: (10.1016/j.fertnstert.2015.08.027) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Figure 4 AFCs per size class to AMH levels for any preovulatory cycle day ≥4 (approach 2). (A) AFCs (y-axis) for AMH levels (x-axis) measured on any preovulatory cycle day ≥4 per size class and in total. AMH levels were stratified to different size classes of antral follicles visible with high-resolution ultrasound. Ultrasound measurement of follicles less than 7 mm in diameter is not very precise, therefore, a summarizing class 2–7 mm is included. All antral follicles of all classes were measured on every visit. The regression lines correspond to the coefficients in Supplemental Table 3. The gray bands represent pointwise 95% prediction intervals (which, for a future patient, cover the follicle count corresponding to the measured AMH level on any preovulatory cycle day ≥4 with a probability of 95%). (B) Prediction intervals for three common coverage probabilities (80%, 90%, 95%). Owing to the larger variance of the random effects, the prediction intervals for this second model are wider. Fertility and Sterility 2015 104, 1535-1543.e4DOI: (10.1016/j.fertnstert.2015.08.027) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions